ABOS icon

Acumen Pharmaceuticals

73 hedge funds and large institutions have $108M invested in Acumen Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 25 increasing their positions, 21 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
73
Holders Change
-8
Holders Change %
-9.88%
% of All Funds
1.06%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
10
Increased
25
Reduced
21
Closed
17
Calls
$226K
Puts
$2.19M
Net Calls
-$1.96M
Net Calls Change
-$588K
Name Holding Trade Value Shares
Change
Shares
Change %
D.E. Shaw & Co
76
D.E. Shaw & Co
New York
-$133K -55,007 Closed
Bank of Montreal
77
Bank of Montreal
Ontario, Canada
-$76.6K -30,885 Closed
MTIM
78
Marathon Trading Investment Management
Pennsylvania
-$63.6K -26,298 Closed
Walleye Capital
79
Walleye Capital
New York
-$45.5K -18,801 Closed
PA
80
Pinnacle Associates
New York
-$43.6K -18,020 Closed
OAM
81
Oxford Asset Management
United Kingdom
-$37K -15,304 Closed
Stifel Financial
82
Stifel Financial
Missouri
-$33K -13,650 Closed
EGM
83
Engineers Gate Manager
New York
-$27.8K -11,479 Closed
GCM
84
Gladius Capital Management
Illinois
-$26.5K -10,939 Closed
CSS
85
Cubist Systematic Strategies
Connecticut
-$21.5K -8,880 Closed
PD
86
Point72 (DIFC)
United Arab Emirates
-$9.72K -4,018 Closed
SSB
87
Sandy Spring Bank
Maryland
-$3.63K -1,500 Closed
KFS
88
Kelly Financial Services
Massachusetts
-$2.29K -944 Closed
RWMG
89
Redwood Wealth Management Group
New Jersey
-$1.94K -800 Closed